S&P 500   4,975.51
DOW   38,563.80
QQQ   427.32
Higher VIX just made Realty Income’s 6% dividend better
Investing Wizard Who Turned $37K Into $2.7M in Just 4 Years Makes His Next Big Move (Ad)
Super Micro Computer: Overbought, undervalued or mispriced?
Booking stock is the discounted growth story in travel stocks
Critical asset just had biggest fall on record (Ad)
3 E-VTOL stocks: Which ones can fly higher in 2024?
Capital One's bid for Discover carries expectation that Americans won't slow credit card use
Critical asset just had biggest fall on record (Ad)
Walmart’s uptrend is intact; buy it when it dips
XPeng stock just got a target boost, analysts say it could double
S&P 500   4,975.51
DOW   38,563.80
QQQ   427.32
Higher VIX just made Realty Income’s 6% dividend better
Investing Wizard Who Turned $37K Into $2.7M in Just 4 Years Makes His Next Big Move (Ad)
Super Micro Computer: Overbought, undervalued or mispriced?
Booking stock is the discounted growth story in travel stocks
Critical asset just had biggest fall on record (Ad)
3 E-VTOL stocks: Which ones can fly higher in 2024?
Capital One's bid for Discover carries expectation that Americans won't slow credit card use
Critical asset just had biggest fall on record (Ad)
Walmart’s uptrend is intact; buy it when it dips
XPeng stock just got a target boost, analysts say it could double
S&P 500   4,975.51
DOW   38,563.80
QQQ   427.32
Higher VIX just made Realty Income’s 6% dividend better
Investing Wizard Who Turned $37K Into $2.7M in Just 4 Years Makes His Next Big Move (Ad)
Super Micro Computer: Overbought, undervalued or mispriced?
Booking stock is the discounted growth story in travel stocks
Critical asset just had biggest fall on record (Ad)
3 E-VTOL stocks: Which ones can fly higher in 2024?
Capital One's bid for Discover carries expectation that Americans won't slow credit card use
Critical asset just had biggest fall on record (Ad)
Walmart’s uptrend is intact; buy it when it dips
XPeng stock just got a target boost, analysts say it could double
S&P 500   4,975.51
DOW   38,563.80
QQQ   427.32
Higher VIX just made Realty Income’s 6% dividend better
Investing Wizard Who Turned $37K Into $2.7M in Just 4 Years Makes His Next Big Move (Ad)
Super Micro Computer: Overbought, undervalued or mispriced?
Booking stock is the discounted growth story in travel stocks
Critical asset just had biggest fall on record (Ad)
3 E-VTOL stocks: Which ones can fly higher in 2024?
Capital One's bid for Discover carries expectation that Americans won't slow credit card use
Critical asset just had biggest fall on record (Ad)
Walmart’s uptrend is intact; buy it when it dips
XPeng stock just got a target boost, analysts say it could double

Navidea Biopharmaceuticals (NAVB) Insider Trading & Ownership

$0.04
0.00 (0.00%)
(As of 02/20/2024 ET)

Navidea Biopharmaceuticals (NYSE:NAVB) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
43.68%
Number Of
Insiders Buying
(Last 3 Years)
2
Amount Of
Insider Buying
(Last 3 Years)
$120,655.00
Number Of
Insiders Selling
(Last 3 Years)
0
Get NAVB Insider Trade Alerts

Want to know when executives and insiders are buying or selling Navidea Biopharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

NAVB Insider Buying and Selling by Quarter


Navidea Biopharmaceuticals Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/26/2021Malcolm G. WitterDirectorBuy15,000$1.70$25,500.00  
4/23/2021Malcolm G WitterDirectorBuy10,000$1.60$16,000.00  
3/29/2021Malcolm G WitterDirectorBuy21,500$2.07$44,505.00  
3/3/2021Malcolm G WitterDirectorBuy15,000$2.31$34,650.00
(Data available from 1/1/2013 forward)












NAVB Insider Trading Activity - Frequently Asked Questions

Who is on Navidea Biopharmaceuticals's Insider Roster?

The list of insiders at Navidea Biopharmaceuticals includes Malcolm G Witter. Learn more on insiders at NAVB.

What percentage of Navidea Biopharmaceuticals stock is owned by insiders?

43.68% of Navidea Biopharmaceuticals stock is owned by insiders. Learn more on NAVB's insider holdings.


More Insider Trading Tools from MarketBeat

This page (NYSE:NAVB) was last updated on 2/21/2024 by MarketBeat.com Staff